CD20, Columbi, DLBCL, Genentech
Glofitamab-gxbm inotenderwa neFDA kune yakasarudzwa yakadzokororwa kana refractory yakakura B-cell lymphomas.
July 2023: The Food and Drug Administration gave accelerated approval to glofitamab-gxbm (Columvi, Genentech, Inc.) for relapsed or refractory diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS) or large B-cell ly..
B-cell lymphoma, DLBCL, POLARIX, Polatuzumab, polatuzumab vedotin
Polatuzumab vedotin-piiq inotenderwa neUSFDA kune yaimbove isina kurapwa yakapararira yakakura B-cell lymphoma, isina kutsanangurwa neimwe nzira, uye yepamusoro-giredhi B-cell lymphoma.
Chivabvu 2023: Kune varwere vakura vane giredhi repamusoro B-cell lymphoma (HGBL), isina kutsanangurwa neimwe nzira (NOS), kana kuparadzira hombe B-cell lymphoma (DLBCL) vasina kumbowana kurapwa uye vane International Prognostic Inde.
MOTO - T Cell kurapwa, Iyo kambani CARsgen Therapeutics Co, Daiichi Sankyo Company, DLBCL, Emergen Research, Zvishoma, Novartis AG
CAR T-Cell therapy musika inokura pamwero wepamusoro mumakore masere anotevera
Chikunguru 2022: Zvinoenderana netsvagiridzo yazvino yakaitwa neEmergen Research, musika wepasi rose weCAR T-cells therapy wakasvika pachiyero cheUS $ 1.29 bhiriyoni muna 2021 uye inotarisirwa kunyoresa mari CAGR ye24.9 muzana.
Burkitt lymphoma, Burkitt-kufanana lymphoma, DLBCL, Genentech, Rituxan, Rituximab
Rituximab pamwe nechemotherapy inotenderwa neFDA kune zviratidzo zvegomarara revana
Kurume 2022: Chikafu neDrug Administration yakabvumidza rituximab (Rituxan, Genentech, Inc.) pamwe chete nechemotherapy yeCD20-positive diffuse hombe B-cell lymphoma (DLBCL), Burkitt lymphoma (BL), Burkitt-like lymphoma.
Iyo kambani ADC Therapeutics SA, alkylating mumiriri conjugate, CD19-inotungamirwa antibody, wide diffuse B-cell lymphoma, DLBCL, yakakwira-giredhi B-cell lymphoma, Yakakura B-cell lymphoma, Loncastuximab tesirine-lpyl, Zynlonta
Iyo FDA yakapa loncastuximab tesirine-lpyl kukurumidza kubvumidzwa kune yakakura B-cell lymphoma
Nyamavhuvhu 2021: Iyo FDA yakapa loncastuximab tesirine-lpyl (Zynlonta, ADC Therapeutics SA), CD19-inotungamirwa antibody uye alkylating mumiriri conjugate, kukurumidza kubvumidzwa kwevakuru varwere vane yakadzokororwa kana yekuratidzira hombe B-cell ly ..
DLBCL, Hodgkin's lymphoma, lymphoma, NHL, Kwete Hodgkin lymphoma
Nei vechidiki vane huwandu hwakanyanya hwe lymphoma?
LymphPeople vane ruzivo rushoma nezve lymph. Mutsipa, zvidya, uye muhapwa zvese lymph. Kana paine dambudziko neiyo lymphatic system, chepfu yemuviri inochengetwa muhuwandu hwakawanda, uye lymphoma ichakurumidza.